At 9.5% CAGR, the Erectile Dysfunction Device Market is expected to

0

SEATTLE, November 17, 2021 (GLOBE NEWSWIRE) – According to Coherent Market Insights, the global market erectile dysfunction device market is estimated at US $ 1,303.8 million in 2021 and is expected to post a CAGR of 9.5% during the forecast period (2021-2028).

Key trends and analysis of Global Erectile Dysfunction Devices Market:

Major market trends include increasing prevalence of erectile dysfunction, increasing product approvals by regulatory authorities, and increasing research and development activity.

For example, according to the International Journal of Impotence Research: 2018, it is estimated that one in 10 men suffers from erectile dysfunction at some point in their life and the global prevalence of erectile dysfunction is expected to reach 322 million men. by 2025.

The increase in product approvals by regulatory authorities is expected to contribute to the growth of the global erectile dysfunction devices market during the forecast period. For example, in 2019, Rigicon, Inc., a global provider of prosthetic urology solutions, received US Food and Drug Administration (FDA) approval for the Rigi10 malleable penile prosthesis to be implanted in bodies. cavernous penis for men diagnosed with erectile dysfunction. The prosthesis is implanted to provide adequate penile stiffness for intercourse.

Request a copy of this report @ https://www.coherentmarketinsights.com/insight/request-sample/27

Many research institutes have started clinical trials to test the safety and effectiveness of erectile dysfunction devices. This is expected to increase the growth of the global erectile dysfunction devices market during the forecast period. For example, the Boston Children’s Hospital, Massachusetts, USA, has initiated clinical trials to test whether an external erectile prosthesis, i.e. the Elator, is a feasible alternative to internal erectile prostheses for transgender men. who have had phalloplasty with glans plastic surgery and wish to use their neophallus for sexual purposes. penetration. The Elator was originally developed for men with erectile dysfunction after prostate cancer. The device consists of two silicone rings connected by a pair of rigid plastic coated metal rods. The study was completed in July 2021.

Key points of the market:

Increasing product launches and approvals, inorganic activities such as collaborations, acquisitions, and others are expected to drive the growth of the global erectile dysfunction devices market during the forecast period. For example, in 2015, The Elator in the United States partnered with The Sinclair Institute for its penis support device for men with erectile dysfunction. The Sinclair Institute offers sexual health products to adults who want to improve the quality of intimacy and better sexual health at any age.

Competitive landscape:

Major players operating in the global erectile dysfunction device market include Boston Scientific Corporation, Coloplast Corp., Zephyr Surgical Implants, Owen Mumford Ltd., Augusta Medical Systems, Storz medical AG, Promedon, The Elator, Timm Medical and Silimed

Buy this research report now @ https://www.coherentmarketinsights.com/insight/buy-now/27

Market segmentation :

  • Global Erectile Dysfunction Devices Market, By Device Type:
    • Non-surgical devices
      • Vacuum constriction devices
      • Shock wave generators for erectile dysfunction
      • External penile stiffness devices
    • Surgical devices
      • Vacuum constriction devices
        • Inflatable implants
        • Malleable implants (semi-rigid)
      • Other surgical devices
  • Global Erectile Dysfunction Devices Market, By End User:
    • Hospitals
    • Clinics
    • Outpatient surgery centers
  • Global Erectile Dysfunction Devices Market, By Region:
      • By country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • By country:
        • UK
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • The rest of europe
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia-Pacific
    • Middle East
      • By country:
        • CCG
        • Israel
        • Rest of the Middle East
      • By country / region:
        • South Africa
        • central Africa
        • North Africa

Related Market Intelligence Reports:

Erectile Dysfunction Treatment Market, by product (Viagra (sildenafil citrate), Cialis (Tadalafil), Stendra / Sperda, Levitra / Staxyn, Zydena (Udenafil) and Vitaros (alprostadil cream)), by distribution channel (hospital pharmacies, online pharmacies and pharmacies of Retail), and by Region (North America, Latin America, Europe, Asia-Pacific, Middle East & Africa) – Size, Share, Outlook and Opportunity Analysis, 2019 – 2027

Sexual health market, by product type (erectile dysfunction drugs, gender dysphoria drugs, hypoactive sex drive drugs, premature ejaculation drugs and others), by sex (male and female), by distribution channel (pharmacies hospitals, retail pharmacies and online pharmacies), and by region (North America, Latin America, Europe, Asia-Pacific, Middle East and Africa) – Analysis of size, share, outlook and opportunities, 2019 – 2027

Lifestyle drugs market, by drug class (phosphodiesterase (PDE) inhibitors, 5-alpha reductase inhibitors, vasodilators, prostamides, neuromuscular blockers, stimulants, contraceptives and antidepressants), by application (erectile dysfunction, baldness, anti-aging, smart drugs and cognitive enhancers, Energy drugs, contraception, obesity, smoking cessation and others), by dosage form (tablets, oral syrups, gels, creams, parenteral gums and chewing gum), by distribution channel (hospital pharmacies, retail pharmacies and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia-Pacific, Middle East & Africa) – Global Industry Analysis, Trends, Prospects and Opportunities, 2021-2028

About Us:

Consistent market information is a global market intelligence and consulting organization that aims to help our plethora of clients achieve transformational growth by helping them make critical business decisions. Our head office is located in India, we have a sales office in the world financial capital in the United States, and sales consultants in the United Kingdom and Japan. Our clientele includes players from various industries in more than 57 countries around the world.

Follow us: LinkedIn | Twitter


        
Share.

Comments are closed.